Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Does FDA Rejection Of Label Warning Shield Manufacturers From Tort Suits?

Executive Summary

US Supreme Court asks Solicitor General to weigh in on Merck petition requesting clarification of its Wyeth v. Levine ruling; Third Circuit says decision is 'cryptic and open-ended.'

Advertisement

Related Content

Supreme Court Docket Includes Four Cases Impacting Pharma Industry
Supreme Court Docket Includes Four Cases Impacting Pharma Industry
Judge Kavanaugh May Be Good US Supreme Court Pick For Pharma
Supreme Court To Clarify Whether Manufacturers Are Shielded From Failure-To-Warn Suits When FDA Rejects Label Warnings
With 5-0 Winning Streak, Bayer And J&J Move To Eliminate Remaining Xarelto Litigation
Brand-Name Drug Makers' Duty To Warn Extends After Product Sale To Another Company
Brand-Name Drug Makers' Duty To Warn Extends After Product Sale To Another Company
Product Liability Litigation Playbook: Pros And Cons For Pharma
Pre-emption After Supreme Court Ruling May Depend On How FDA Weighs Risk

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS122077

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel